JP2014508810A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508810A5
JP2014508810A5 JP2014501251A JP2014501251A JP2014508810A5 JP 2014508810 A5 JP2014508810 A5 JP 2014508810A5 JP 2014501251 A JP2014501251 A JP 2014501251A JP 2014501251 A JP2014501251 A JP 2014501251A JP 2014508810 A5 JP2014508810 A5 JP 2014508810A5
Authority
JP
Japan
Prior art keywords
transdermal composition
composition according
agent
transdermal
conversion layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014501251A
Other languages
English (en)
Japanese (ja)
Other versions
JP5906302B2 (ja
JP2014508810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/030171 external-priority patent/WO2012129429A2/en
Publication of JP2014508810A publication Critical patent/JP2014508810A/ja
Publication of JP2014508810A5 publication Critical patent/JP2014508810A5/ja
Application granted granted Critical
Publication of JP5906302B2 publication Critical patent/JP5906302B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2014501251A 2011-03-24 2012-03-22 作用剤層および作用剤変換層を含む経皮組成物 Expired - Fee Related JP5906302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467337P 2011-03-24 2011-03-24
US61/467,337 2011-03-24
PCT/US2012/030171 WO2012129429A2 (en) 2011-03-24 2012-03-22 Transdermal compositions comprising an active agent layer and an active agent conversion layer

Publications (3)

Publication Number Publication Date
JP2014508810A JP2014508810A (ja) 2014-04-10
JP2014508810A5 true JP2014508810A5 (enExample) 2014-12-11
JP5906302B2 JP5906302B2 (ja) 2016-04-20

Family

ID=46880045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014501251A Expired - Fee Related JP5906302B2 (ja) 2011-03-24 2012-03-22 作用剤層および作用剤変換層を含む経皮組成物

Country Status (7)

Country Link
US (2) US9119799B2 (enExample)
EP (1) EP2688561B1 (enExample)
JP (1) JP5906302B2 (enExample)
KR (1) KR101853082B1 (enExample)
CN (1) CN103476404B (enExample)
TW (1) TWI442948B (enExample)
WO (1) WO2012129429A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011139420A2 (en) 2010-04-30 2011-11-10 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
KR20150059177A (ko) * 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
CA2906796A1 (en) * 2013-03-15 2014-09-25 Nal Pharmaceuticals Ltd. Transdermal drug delivery system containing rivastigmine
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
US20170291020A1 (en) * 2016-04-12 2017-10-12 Mylan Inc. Double disk transdermal system
CN107789628B (zh) * 2016-12-29 2021-07-23 天津键凯科技有限公司 一种聚乙二醇和局部麻醉药的结合物在非麻醉镇痛中的应用
EP3870172A1 (en) * 2018-10-24 2021-09-01 Saniona A/S Transdermal tropane compositions and methods for using the same
US11752114B2 (en) 2019-04-17 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
JP7453994B2 (ja) * 2019-04-17 2024-03-21 エルテーエス ローマン テラピー-ジステーメ アーゲー 経皮治療システム
EP3725306A1 (en) * 2019-04-17 2020-10-21 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system
KR102155108B1 (ko) * 2019-11-27 2020-09-11 주식회사 우신라보타치 라사길린 또는 그의 약학적으로 허용가능한 염을 함유하는 경피흡수제제
CN117860708A (zh) * 2022-10-11 2024-04-12 姜钦治 含有普拉克索和雷沙吉兰的透皮贴片

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4588740A (en) 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
GB8712073D0 (en) 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
DE69009540T2 (de) 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
JP2849937B2 (ja) 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5462746A (en) 1992-11-02 1995-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
JP2539330B2 (ja) 1993-05-11 1996-10-02 日東電工株式会社 医療用粘着剤及びこれを用いて形成された医療用外用材
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US5391406A (en) 1994-03-25 1995-02-21 National Starch And Chemical Investment Holding Corporation Process of preparing hot melt pressure sensitive adhesives on a substrate
JP3604177B2 (ja) 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
JP3576608B2 (ja) 1994-11-15 2004-10-13 日東電工株式会社 貼付剤および貼付製剤
DE19533772C1 (de) 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
DE19628999C1 (de) 1996-07-18 1998-03-12 Lohmann Gmbh & Co Kg Medizinische Haftklebstoffe mit hoher Wasserdampfdurchlässigkeit und Klebkraft und damit versehene Pflaster und ihre Verwendung
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US6132761A (en) 1997-09-05 2000-10-17 Nitto Denko Corporation Percutaneous absorption preparation
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
ATE314092T1 (de) 1997-09-26 2006-01-15 Noven Pharma Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
US6809120B1 (en) 1998-01-13 2004-10-26 University Of Saskatchewan Technologies Inc. Composition containing propargylamine for enhancing cancer therapy
US6146656A (en) 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
DE19814087A1 (de) 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
WO2000032144A1 (en) 1998-12-02 2000-06-08 Nichiban Co., Ltd. Pressure-sensitive adhesive tape for pasting on skin and base material for use therein
EP1137406B2 (en) 1998-12-07 2008-01-23 J. Dev Limited Transdermal patch for delivering volatile liquid drugs
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
US6218421B1 (en) 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
WO2001052823A2 (en) 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
US6277875B1 (en) 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10035891A1 (de) 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
US20070225379A1 (en) 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
JP4057418B2 (ja) 2000-11-07 2008-03-05 久光製薬株式会社 経皮吸収型製剤
DE10060852A1 (de) 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
WO2002069974A1 (en) 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
US20030212085A1 (en) 2001-04-17 2003-11-13 Mccall Robert B. Treatment of fibromyalgia and chronic fatigue syndrome
DE10137162A1 (de) 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20050186141A1 (en) 2002-06-25 2005-08-25 Acrux Dds Pty Ltd. Transdermal aerosol compositions
JP5160018B2 (ja) 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
EP2526944B1 (en) 2002-11-15 2016-06-01 Teva Pharmaceutical Industries Limited Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US20040242669A1 (en) 2003-05-27 2004-12-02 Filippo Drago Method of treating deficits associated with brain injury
WO2005009417A1 (en) 2003-07-21 2005-02-03 Noven Pharmaceuticals, Inc. Composition and method for controlling grug delivery from silicone adhesive blends
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
US7378439B2 (en) 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
JP2005232148A (ja) 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
EP1742624B1 (en) 2004-02-18 2010-01-06 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
JP4961207B2 (ja) * 2004-04-21 2012-06-27 久光製薬株式会社 粘着基剤中の吸収促進剤の含有率を高めた外用貼付剤
ITMI20041628A1 (it) 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
MX2007004315A (es) 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
CA2600008A1 (en) 2005-02-22 2006-11-16 Teva Pharmaceutical Industries Ltd. Improved process for the synthesis of enantiomeric indanylamine derivatives
KR20140103356A (ko) 2005-02-23 2014-08-26 테바 파마슈티컬 인더스트리즈 리미티드 함량 균일성이 개선된 라사길린 제형
US20070078172A1 (en) 2005-06-16 2007-04-05 Jenrin Discovery Mao-b inhibitors useful for treating obesity
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
EP1954667B1 (en) 2005-11-17 2017-02-08 Teva Pharmaceutical Industries Ltd Methods for isolating propargylated aminoindans
US7572834B1 (en) 2005-12-06 2009-08-11 Teva Pharmaceutical Industries, Ltd. Rasagiline formulations and processes for their preparation
CN101032474B (zh) * 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
CA2647801C (en) 2006-03-24 2015-04-14 Auxilium Pharmaceuticals, Inc. Process for the preparation of a hot-melt extruded laminate
CN101420946B (zh) 2006-04-11 2011-05-25 日绊株式会社 含有坦索罗辛的透皮吸收型制剂
US20070254941A1 (en) 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
JP2010508289A (ja) * 2006-10-27 2010-03-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド ケトプロフェン極性誘導体の経皮的送達
EA016820B1 (ru) 2006-12-14 2012-07-30 Тева Фармасьютикал Индастриз, Лтд. Кристаллическое твердое основание разагилина
US20090043111A1 (en) 2007-08-06 2009-02-12 Meizheng Liu Novel process for ropinirole preparation
DE102007041557B4 (de) 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
EP2194780A4 (en) 2007-09-05 2010-10-27 Teva Pharma METHOD FOR TREATING GLAUCOMA BY RASAGILINE
US8188149B2 (en) 2007-09-17 2012-05-29 Teva Pharmaceutical Industries, Ltd. Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
US20110028880A1 (en) 2008-02-27 2011-02-03 Hisamitsu Pharmaceutical Co., Inc. Patch
US20090291127A1 (en) 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
CA2727021A1 (en) 2008-06-19 2009-12-23 Teva Pharmaceutical Industries Ltd. Process for purifying rasagiline base
CN101606923B (zh) 2008-06-20 2013-01-09 重庆医药工业研究院有限责任公司 一种稳定的控释释放的雷沙吉兰透皮贴片及其制备方法
WO2010008600A1 (en) 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US20100029987A1 (en) 2008-07-29 2010-02-04 Dipharma Francis S.R.I. Crystalline Form of Rasagiline and Process for the Preparation Thereof
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
WO2011005853A2 (en) 2009-07-08 2011-01-13 Msk Pharma, Llc Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
WO2011139420A2 (en) * 2010-04-30 2011-11-10 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
CN102475692A (zh) 2010-11-29 2012-05-30 重庆医药工业研究院有限责任公司 一种防止雷沙吉兰挥发的透皮贴片

Similar Documents

Publication Publication Date Title
JP2014508810A5 (enExample)
JP2009185061A5 (enExample)
JP2010254979A5 (enExample)
JP2009292868A5 (enExample)
JP2011523650A5 (enExample)
JP2013511594A5 (enExample)
JP2013523913A5 (enExample)
EP2404972A3 (en) Double-coated pressure-sensitive adhesive tape
JP2010536960A5 (ja) 重合可能な官能基を含むポリビニルアミドポリマー
JP2014224227A5 (ja) 粘着剤組成物および粘着シート
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
JP2013163782A5 (enExample)
JP2016135878A5 (enExample)
JP2014531501A5 (enExample)
JP2016504368A5 (enExample)
EP2135908A3 (en) Pressure-sensitive adhesive composition and pressure-sensitive adhesive sheet to be attached to metal surface
JP2013185008A5 (enExample)
JP2014019799A5 (enExample)
JP2014025007A5 (enExample)
JP2013521383A5 (enExample)
JP2013107978A5 (enExample)
JP2012504163A5 (enExample)
JP2015117347A5 (enExample)
CA2561361A1 (en) Crosslinkable pressure-sensitive adhesive for the skin
JP2015507683A5 (enExample)